Andrew SP Sharp

Andrew SP Sharp

Consultant Cardiologist

FRCP MB MBBCh

University Hospital of Wales, Cardiff, Wales, UK

  • LinkedIn
  • X
  • Radcliffe

Biography

Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.

Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.

Andrew's specialist interests include the pharmacological and interventional treatment of resistant hypertension (including renal denervation); intra-coronary physiology to assess the causes of chest pain; complex angioplasty and stenting of coronary artery disease and CT coronary angiography.

Dr Andrew Sharp is Deputy Editor (Development) of Interventional Cardiology: Reviews, Research, Resources (ICR3)

Read more

Media

Science of Renal Denervation Technology

Andrew SP Sharp, Stefan Tunev,

Watch time: 20m 50s

Andrew SP Sharp, Atul Pathak, Felix Mahfoud, et al

Watch time: 1h 17s

José M de la Torre Hernández, Tamara García Camarero, Andrew SP Sharp, et al

Watch time: 1h 39m 31s
Part 2: PoTS sub-types (neuropathic/hyperadrenergic/volume dysregulation etc…)

Andrew SP Sharp, Melvin D Lobo, Lesley Kavi, et al

Watch time: 12m 39s
PART 3: Comorbidities in PoTS (Breathing/Gut/GUS/Neuro)

Andrew SP Sharp, Melvin D Lobo, Lesley Kavi, et al

Watch time: 15m 49s
Part 4: Non-pharmacological management of PoTS

Andrew SP Sharp, Melvin D Lobo, Lesley Kavi, et al

Watch time: 11m 58s
Part 5: Drug therapy of PoTS: Rhythm control, Circulatory control

Andrew SP Sharp, Melvin D Lobo, Lesley Kavi, et al

Watch time: 11m 47s
Part 6: The Future of PoTS - Gall

Andrew SP Sharp, Melvin D Lobo, Nick Gall, et al

Watch time: 14m 22s
Part 1: PoTS definition, epidemiology & diagnosis

Andrew SP Sharp, Melvin D Lobo, Lesley Kavi, et al

Watch time: 16m 41s

Stefan Tunev, Andrew SP Sharp,

Watch time: 1h 12m 55s
The science of renal denervation - Part 1

Stefan Tunev, Andrew SP Sharp,

Watch time: 30m 24s

Andrew SP Sharp, Atul Pathak, Roland E Schmieder, et al

Watch time: 1h 29m 27s (3 videos)

Andrew SP Sharp,

Watch time: 1h 10s
TCT 2019: RF renal denervation - Prof Andrew Sharp

Andrew SP Sharp,

Watch time: 9m 14s
ESC 2018: Rationale For New Treatment Options For Intermediate

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s

Andrew SP Sharp, Indranil Dasgupta, Felix Mahfoud, et al

Watch time: 1h 13m 4s
ESC 2018: Rationale for New Treatment Options for Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 19m 4s
New Treatment Options For Intermediate-High Risk PE

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Andrew SP Sharp, Adriaan Kraaijeveld, Nicolas Meneveau, et al

Watch time: 14m 32s
Symposium at ESC Congress 2018 sponsored by EKOS Corporation

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 5m 49s

Robert Gerber, Andrew SP Sharp,

Watch time: 58m 14s
ESC 2017: Catheter-Based Renal Denervation

Andrew SP Sharp,

Watch time: 6m 42s
Optimum Duration Of Acoustic Pulse Thrombolysis Procedure

Andrew SP Sharp,

Watch time: 8m 38s

Andrew SP Sharp, Takashi Akasaka, Carlo Di Mario, et al

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Image

Simon Kennon, Stephan Achenbach, Sergio Baptista, et al

Watch time: 17m 54s
EuroPCR 2015: Update on iFR and FFR

Simon Kennon, Andrew SP Sharp,

Watch time: 13m 53s
EuroPCR 2015: Renal Denervation: The UK Experience

Simon Kennon, Andrew SP Sharp,

Watch time: 13m 46s

Articles by Andrew SP Sharp, Consultant Cardiologist

Can Interventional Cardiologists Help Deliver the UK Mechanical Thrombectomy Interventional Programme for Patients with Acute Ischaemic Stroke? A Discussion Paper from the British Cardiovascular Interventional Society Stroke Thrombectomy Focus Group

Helen Routledge, Andrew SP Sharp, Jan Kovac, et al

Published:

Citation: Interventional Cardiology 2022;17:e07.

DOI:

https://doi.org/10.15420/icr.2021.35
Use of intravascular ultrasound (IVUS) in ambiguous angiograms

Andrew SP Sharp,

Published:

Citation: RadcliffeCardiology.com, September 2018

DOI:

https://doi.org/10.15420/rc.2018.m015
Fractional Flow Reserve: Does a Cut-off Value add Value?

Shah R Mohdnazri, Thomas R Keeble, Andrew SP Sharp, et al

Citation: Interventional Cardiology Review 2016;11(1):17–26

DOI:

https://doi.org/10.15420/icr.2016:7:2